(MedPage Today) — The use of potent aldehyde dehydrogenase 1 A1 (ALDH1A1)-activating proton pump inhibitors (PA-PPIs) was associated with inferior survival outcomes in patients with newly diagnosed glioblastoma, according to a retrospective meta…
Private member bill seeks to establish central optical devices quality control and vision care regulation
The proposed bill seeks to offer remedy to the alleged vulnerability of consumers who according to the bill are in a “no-man’s...






